甲基酸盐受体4介导的谷氨酸基信号通过调节树突细胞成熟来重塑瘤微环境
Xiaoman Ju1, Eva Maria Putz2, Yaqi Liu1
1Department of Pathogen Biology and Immunology, Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Nature communications
|July 2, 2025
概括
甲基增生谷氨酸受体4 (mGluR4) 缺乏会增强树突细胞功能,增强抗瘤免疫力. 这种非神经元机制在临床前模型中抑制瘤生长和转移,突出显示mGluR4作为免疫治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
- 在瘤学瘤学.
背景情况:
- 甲基酸盐受体4 (mGluR4) 与瘤进展和免疫调节有关.
- 它通过非神经元途径在瘤微环境 (TME) 中的作用在很大程度上尚未被探索.
研究的目的:
- 调查mGluR4在调节TME内的免疫反应中的非神经元作用.
- 为了确定mGluR4缺乏是否影响瘤生长和相关的免疫细胞活性.
主要方法:
- 使用了缺乏Grm4 (Grm4-/-) 的小鼠和各种临床前瘤模型 (肝脏,黑色素瘤,结肠直肠,纤维肉瘤).
- 评估树突细胞 (DC) 迁移,成熟和抗原呈现.
- 通过单细胞RNA测序和ex vivo试验,分析了TME中的免疫细胞群和功能.
- 研究了腺环酶/PKA信号通路和DC代谢重编程.
主要成果:
- 缺乏mGluR4的小鼠表现出抑制瘤生长和转移.
- 来自Grm4-/-小鼠的DC显示出增强的迁移,成熟和抗原呈现,促进T细胞和NK细胞的反应.
- 瘤抑制依赖于宿主免疫 (CD8+ T细胞,NK细胞,IFNγ) 并独立于神经系统.
- 发现mGluR4抑制了腺环酶/PKA通路,导致DC代谢重编程.
结论:
- mGluR4通过非神经元机制作为TME中DC成熟和免疫反应的检查点.
- 向mGluR4代表了癌症治疗的潜在免疫治疗策略.
- 通过mGluR4抑制或途径调制恢复直流功能的治疗方法具有前景.
相关概念视频
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Enzyme-linked Receptors
80.1K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
80.1K
Interactions Between Signaling Pathways
6.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K


